Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Cancer Therapies02:49

Cancer Therapies

10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

449
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
449
Uncertainty in Measurement: Accuracy and Precision03:37

Uncertainty in Measurement: Accuracy and Precision

102.4K
Scientists typically make repeated measurements of a quantity to ensure the quality of their findings and to evaluate both the precision and the accuracy of their results. Measurements are said to be precise if they yield very similar results when repeated in the same manner. A measurement is considered accurate if it yields a result that is very close to the true or the accepted value. Precise values agree with each other; accurate values agree with a true value. 
102.4K
Gene Therapy00:59

Gene Therapy

27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Accuracy and Precision01:52

Accuracy and Precision

15.5K
Scientists typically make repeated measurements of a quantity to ensure the quality of their findings and to evaluate both the precision and the accuracy of their results. Measurements are said to be precise if they yield very similar results when repeated in the same manner. A measurement is considered accurate if it yields a result that is very close to the true or the accepted value. Precise values agree with each other; accurate values agree with a true value.  Highly accurate...
15.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

BMC medical research methodology·2022
Same author

Genomic landscape of treatment refractory metastatic colorectal cancer.

Acta oncologica (Stockholm, Sweden)·2021
Same author

Modulation of soleus stretch reflexes during walking in people with chronic incomplete spinal cord injury.

Experimental brain research·2019
Same author

Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer.

Clinica chimica acta; international journal of clinical chemistry·2018
Same author

IUGR decreases cardiomyocyte endowment and alters cardiac metabolism in a sex- and cause-of-IUGR-specific manner.

American journal of physiology. Regulatory, integrative and comparative physiology·2018
Same author

International journal of sports medicine·2018

Related Experiment Video

Updated: Feb 7, 2026

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

6.8K

Targeted therapies in biliary tract cancer-when precision becomes imprecise.

C J O'Rourke1, J V Schou2, J B Andersen1

  • 1Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen.

ESMO Gastrointestinal Oncology
|February 6, 2026
PubMed
Summary

Targeted therapies offer benefits for advanced biliary tract cancers (BTCs) with specific alterations. However, resistance mechanisms limit patient response, necessitating refined molecular criteria for better treatment selection and combination therapies.

Keywords:
biliary tract cancergenomicspredictive biomarkersprimary resistancetargeted therapies

More Related Videos

Using a Whole-mount Immunohistochemical Method to Study the Innervation of the Biliary Tract in Suncus murinus
07:23

Using a Whole-mount Immunohistochemical Method to Study the Innervation of the Biliary Tract in Suncus murinus

Published on: June 15, 2017

7.2K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K

Related Experiment Videos

Last Updated: Feb 7, 2026

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

6.8K
Using a Whole-mount Immunohistochemical Method to Study the Innervation of the Biliary Tract in Suncus murinus
07:23

Using a Whole-mount Immunohistochemical Method to Study the Innervation of the Biliary Tract in Suncus murinus

Published on: June 15, 2017

7.2K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K

Area of Science:

  • Oncology
  • Gastroenterology
  • Molecular Biology

Background:

  • Advanced biliary tract cancers (BTCs) show promise for targeted therapies due to actionable genetic alterations.
  • Fibroblast growth factor receptor (FGFR) inhibitors and isocitrate dehydrogenase 1 (IDH1) inhibitors are approved for specific BTC subtypes.
  • A subset of patients does not respond to targeted therapies, even with molecularly matched criteria, indicating unmet needs.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying resistance to targeted therapies in advanced BTCs.
  • To identify novel biomarkers and refine patient selection criteria for targeted treatments.
  • To explore strategies for overcoming therapeutic resistance and improving patient outcomes.

Main Methods:

  • Analysis of genetic (DNA) and non-genetic (transcriptional, translational, post-translational) alterations in signaling networks.
  • Identification of co-occurring resistance biomarkers in BTC tumors.
  • Correlation of molecular profiles with therapeutic response and resistance patterns.

Main Results:

  • BTCs exhibit oncogenic addiction to signaling networks, not just individual genes, contributing to resistance.
  • Primary resistance is mediated by alterations in pathways upstream, downstream, or parallel to the targeted alteration.
  • Limited duration of response suggests complex resistance mechanisms beyond the primary target.

Conclusions:

  • Refining molecular criteria to include resistance biomarkers is crucial for patient selection.
  • Understanding resistance mechanisms will enable the development of next-generation combination therapies.
  • Improved patient stratification and combination strategies can maximize treatment benefits and prolong response duration in BTCs.